The Valley Desk

NCT06541847 · Interventional trial

A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1

Overall registry status Recruiting

Phase 2

Conditions Neurofibromatosis Type 1

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov